Yttrium Y 90 ibritumomab tiuxetan
An anticancer drug that is a combination of the radioisotope yttrium-90 and a monoclonal antibody, a produced substances that can locate and bind to cancer cells.
Also called IDEC-Y2B8 monoclonal antibody
Medical disclaimer
The information on this page is for educational and informational purposes only and does not constitute medical advice in any way.
- It does not replace the advice of a physician, pharmacist or other healthcare professional.
- It does not represent a prescription of drugs, diagnostic exams or therapies.
- In case of symptoms, doubts or concerns about your health, always consult a qualified physician.
In case of emergency call 911 (US) or 112 (EU).